Kate L Costeloe

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. doi request reprint Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial
    Kate Costeloe
    Centre for Paediatrics, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK Electronic address
    Lancet 387:649-60. 2016
  2. pmc Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)
    Kate L Costeloe
    Centre for Paediatrics, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    BMJ 345:e7976. 2012

Detail Information

Publications2

  1. doi request reprint Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial
    Kate Costeloe
    Centre for Paediatrics, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK Electronic address
    Lancet 387:649-60. 2016
    ..We aimed to test the effectiveness of the probiotic Bifidobacterium breve BBG-001 to reduce necrotising enterocolitis, late-onset sepsis, and death in preterm infants...
  2. pmc Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)
    Kate L Costeloe
    Centre for Paediatrics, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    BMJ 345:e7976. 2012
    ..To determine survival and neonatal morbidity for babies born between 22 and 26 weeks' gestation in England during 2006, and to evaluate changes in outcome since 1995 for babies born between 22 and 25 weeks' gestation...